z-logo
open-access-imgOpen Access
Evaluation of the IMMY ALPHA Histoplasma Antigen Enzyme Immunoassay for Diagnosis of Histoplasmosis Marked by Antigenuria
Author(s) -
Ann M. LeMonte,
Lindsey Egan,
Patricia Connolly,
Michelle Durkin,
L. Joseph Wheat
Publication year - 2007
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00035-07
Subject(s) - histoplasmosis , immunoassay , histoplasma , antigen , enzyme , virology , alpha (finance) , immunology , histoplasma capsulatum , microbiology and biotechnology , medicine , chemistry , antibody , biology , biochemistry , cronbach's alpha , clinical psychology , psychometrics
The sensitivity of detection of antigenuria in patients positive by the MiraVista Diagnostics Histoplasma enzyme immunoassay (MVD EIA) was 44% with the IMMY ALPHA Histoplasma antigen EIA. The specificity was 84% with the IMMY EIA versus 98% with the MVD EIA. The correlation between assays for positive cases was weak (r(2) = 0.430).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom